ReShape Lifesciences Inc.

NASDAQ:RSLS   11:49:51 AM EDT
0.83
+0.01 (+0.64%)
Earnings Announcements

ReShape Lifesciences Reports Year Ended 2021 Financial And Operating Results

Published: 03/28/2022 20:20 GMT
ReShape Lifesciences Inc. (RSLS) - Reshape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update.
Reshape Lifesciences Inc - Cash and Cash Equivalents Were $22.8 Million As of December 31, 2021.
Reshape Lifesciences Inc - Revenue for Year Ended December 31, 2021, Was $13.6 Million Compared to $11.3 Million for Year Ended December 31, 2020.
Revenue is expected to be $3.22 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $4.49 Million
Next Quarter EPS Guidance is expected to be -$0.31

More details on our Analysts Page.